about
Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and DithiobenzanilidesAntitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.Biological activity of piceatannol: leaving the shadow of resveratrol.High Potency of a Novel Resveratrol Derivative, 3,3',4,4'-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and RepairDifferent effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity.Colorectal cancer-promoting activity of the senescent peritoneal mesotheliumExpression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell lines3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases.3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.How to design a potent, specific, and stable angiotensin-converting enzyme inhibitor.Cellular changes, molecular pathways and the immune system following photodynamic treatment.Chemistry and pharmacology of Angiotensin-converting enzyme inhibitors.COX-2 inhibitors: a novel strategy in the management of breast cancer.Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells.Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells.Characterization of new eye drops with choline salicylate and assessment of their irritancy by in vitro short time exposure tests.Cytotoxic activity of physodic acid and acetone extract from Hypogymnia physodes against breast cancer cell lines.Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy.Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo.Modulating potential of L-sulforaphane in the expression of cytochrome p450 to identify potential targets for breast cancer chemoprevention and therapy using breast cell lines.DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer.Effects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogs.Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.Folic acid-conjugated core/shell ZnS:Mn/ZnS quantum dots as targeted probes for two photon fluorescence imaging of cancer cells.Cytotoxicity, acute and subchronic toxicity of ionic liquid, didecyldimethylammonium saccharinate, in rats.Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro.Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase.Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition.The European Registered Toxicologist (ERT): Current status and prospects for advancement.The mutagenicity analysis of imidapril hydrochloride and its degradant, diketopiperazine derivative, nitrosation mixtures by in vitro Ames test with two strains of Salmonella typhimuriumAntimicrobial and anticancer photodynamic activity of a phthalocyanine photosensitizer with N-methyl morpholiniumethoxy substituents in non-peripheral positions.Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.Modulation of antioxidant defence system by dietary fat in rats intoxicated with o-toluidine.Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.Protective effect of Aquilegia vulgaris (L.) on APAP-induced oxidative stress in rats.Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship.EPR Oximetry Sensor-Developing a TAM Derivative for In Vivo Studies.Antioxidant activity of isocytisoside and extracts of Aquilegia vulgaris.Activity of NADPH-cytochrome P-450 reductase of the human heart, liver and lungs in the presence of (-)-epigallocatechin gallate, quercetin and resveratrol: an in vitro study.
P50
Q28552026-B93E5C76-10A7-4059-8E4E-DBE5562DB85DQ33261565-75951EFA-3CBC-4AA5-8242-AA9A1FCF3827Q34235213-835E2A4B-FF18-4E4D-BC88-E20FE44F4280Q35851696-D703E039-AC9B-47B3-8278-EF3000CC31B2Q36467387-8F155540-6BA4-4028-8E98-D85E7E4DEE29Q36557249-3888581F-D641-43C7-8B1F-9D770606CBE0Q37210214-868661C1-F7C5-41CB-8B2F-4F44FFDDB1D3Q37227746-58DDA750-56D2-4576-9B99-E635814F8BF3Q37603491-6993C8D6-1D7A-4B96-937C-BA6C6DE90DF9Q37735173-AF19C461-6644-4D3B-81E1-7B9A5EF8672BQ38226540-35D4DE6F-DFB0-4DED-AD2D-96ED00FD22F1Q38245007-78BE4FB8-F18D-4204-8784-59F98BFC41B2Q38267285-C5A992F5-E4A6-445B-A9E4-BAF6E20CCFFAQ38685004-D830F801-D39D-43A8-B359-E41B77A0BB4DQ38723144-EA562D11-A053-4A48-A3FC-941694DED1EFQ38740423-53B07AB6-9CEA-4985-A650-0ABF9AF01FEEQ38773949-621BD1FC-BDF8-406D-B42B-FD87F2A111F9Q38780355-604179E8-4F43-4DE4-B396-3AD2A7584CADQ38907822-C596C1D2-852B-488F-8B96-6E5BBC2796A4Q38949227-CA3CF757-DF5B-4BFB-AEF1-FFDBF3241342Q38955333-23EF86DE-2E44-4C81-AA5C-6E801A266A87Q39001155-24A30E1B-E216-4A8B-888F-9F6AEAF19C36Q39036742-7BB4FFF2-6AB3-43CB-A12F-C80A52DF4E7EQ39093334-641DA3F2-4144-4A0B-B72E-D09EE5CDC70DQ39641379-36BE2787-43F8-4BE6-83CE-64946E2B5840Q39721782-1102DDBE-CF5B-4342-A402-3F895F544F54Q39801167-2DAFBBDE-F267-4C8D-9162-3B130412B657Q39988794-4AE59601-D878-4777-8AB7-87BE79ABDB66Q40035042-89177B2D-02D9-4B67-BED0-6B7BAB1B8C15Q40682256-D0705847-242E-4942-9820-0177A72DB687Q41883454-6F135DFB-32B5-46E7-9BC8-FA5662249ABDQ42508807-B60B65AD-475E-4018-A120-F7AADE8EE2CEQ42698392-DD9C5277-8D58-46CD-B3AB-F7CD9EE71913Q44286076-D379F0C6-841C-4FF1-85F7-9ECF0C07FF7AQ45090641-48F9C15F-B772-4C53-A783-444F08090A7FQ45262598-870C3BE7-5BE9-456E-A1F5-6FCE2B2930F8Q45302719-6CBAE97D-CB81-43B0-81CD-237074544F33Q46176263-18A5912D-1553-4243-8DE3-E050F4EB88C9Q46557493-883F863B-4771-4B77-B37D-40A94B2AE7C7Q46584509-C09BC28D-C53F-4296-8C24-CC4606542F99
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marek Murias
@ast
Marek Murias
@en
Marek Murias
@es
Marek Murias
@nl
type
label
Marek Murias
@ast
Marek Murias
@en
Marek Murias
@es
Marek Murias
@nl
prefLabel
Marek Murias
@ast
Marek Murias
@en
Marek Murias
@es
Marek Murias
@nl
P1053
A-3776-2015
P106
P1153
6602214898
P21
P31
P496
0000-0002-2903-4912